SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-367000
Filing Date
2021-12-27
Accepted
2021-12-27 16:05:57
Documents
14
Period of Report
2021-12-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d192254d8k.htm   iXBRL 8-K 31582
2 EX-10.1 d192254dex101.htm EX-10.1 58943
3 EX-10.2 d192254dex102.htm EX-10.2 58747
  Complete submission text file 0001193125-21-367000.txt   312597

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cogt-20211224.xsd EX-101.SCH 2896
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20211224_lab.xml EX-101.LAB 18889
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20211224_pre.xml EX-101.PRE 11863
8 EXTRACTED XBRL INSTANCE DOCUMENT d192254d8k_htm.xml XML 3472
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 211520409
SIC: 2834 Pharmaceutical Preparations